Evidence map›Paper›PMID 22879904›Full record

ArticlePloS one2012

Inhaled carbon monoxide provides cerebral cytoprotection in pigs.

Vicki L Mahan, David Zurakowski, Leo E Otterbein, Frank A Pigula

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. "CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Carbon monoxide and the CNS: challenges and achievements.British journal of pharmacology · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Vicki L MahanDepartment of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America. vmahan@bidmc.harvard.edu
David Zurakowski
Leo E Otterbein
Frank A Pigula
Boston Children's Hospital · USBeth Israel Deaconess Medical Center · USHarvard University · US

Funding

Endogenous Gas Molecules As Transcription FactorsR01GM088666 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI OTTERBEIN, LEO E · 2009 to 2012
$1.4M
HemeOxygenase-1 and Transplant ToleranceR56AI092272 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI OTTERBEIN, LEO E · 2011 to 2011
$305k
NIAID NIH HHS R56 AI092272NIAID NIH HHS R56AI092272NIGMS NIH HHS 5R01GM088666NIGMS NIH HHS R01 GM088666
6 · The paper itself

Abstract

Carbon monoxide (CO) at low concentrations imparts protective effects in numerous preclinical small animal models of brain injury. Evidence of protection in large animal models of cerebral injury, however, has not been tested. Neurologic deficits following open heart surgery are likely related in part to ischemia reperfusion injury that occurs during cardiopulmonary bypass surgery. Using a model of deep hypothermic circulatory arrest (DHCA) in piglets, we evaluated the effects of CO to reduce cerebral injury. DHCA and cardiopulmonary bypass (CPB) induced significant alterations in metabolic demands, including a decrease in the oxygen/glucose index (OGI), an increase in lactate/glucose index (LGI) and a rise in cerebral blood pressure that ultimately resulted in increased cell death in the neocortex and hippocampus that was completely abrogated in piglets preconditioned with a low, safe dose of CO. Moreover CO-treated animals maintained normal, pre-CPB OGI and LGI and corresponding cerebral sinus pressures with no change in systemic hemodynamics or metabolic intermediates. Collectively, our data demonstrate that inhaled CO may be beneficial in preventing cerebral injury resulting from DHCA and offer important therapeutic options in newborns undergoing DHCA for open heart surgery.

Indexed as

Administration, InhalationAnimalsApoptosisArterial PressureBrainCarbon MonoxideCardiopulmonary BypassCytoprotectionFemaleGlucoseIn Situ Nick-End LabelingLactic AcidNeuronsOxygenSus scrofaCarbon MonoxideGlucoseLactic AcidOxygen

Identifiers

PMID22879904
PMCPMC3413707
OpenAlexW2135917951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.